Does PACLITAXEL Cause Breast cancer recurrent? 151 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 151 reports of Breast cancer recurrent have been filed in association with PACLITAXEL (PACLITAXEL PACLITAXEL). This represents 0.2% of all adverse event reports for PACLITAXEL.
151
Reports of Breast cancer recurrent with PACLITAXEL
0.2%
of all PACLITAXEL reports
19
Deaths
18
Hospitalizations
How Dangerous Is Breast cancer recurrent From PACLITAXEL?
Of the 151 reports, 19 (12.6%) resulted in death, 18 (11.9%) required hospitalization, and 7 (4.6%) were considered life-threatening.
Is Breast cancer recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PACLITAXEL. However, 151 reports have been filed with the FAERS database.
What Other Side Effects Does PACLITAXEL Cause?
Neutropenia (4,553)
Nausea (4,521)
Dyspnoea (4,519)
Diarrhoea (4,289)
Off label use (4,075)
Anaemia (3,949)
Neuropathy peripheral (3,508)
Malignant neoplasm progression (3,484)
Fatigue (3,418)
Death (3,143)
What Other Drugs Cause Breast cancer recurrent?
LETROZOLE (285)
TRASTUZUMAB (268)
TAMOXIFEN (260)
FULVESTRANT (219)
ANASTROZOLE (214)
CYCLOPHOSPHAMIDE (182)
RIBOCICLIB (180)
DOCETAXEL (138)
PALBOCICLIB (126)
DOXORUBICIN (114)
Which PACLITAXEL Alternatives Have Lower Breast cancer recurrent Risk?
PACLITAXEL vs PACRITINIB
PACLITAXEL vs PALBOCICLIB
PACLITAXEL vs PALIPERIDONE
PACLITAXEL vs PALIVIZUMAB
PACLITAXEL vs PALONOSETRON